Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.04.510847Source: DataRank Database

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (47)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Tomoko Hayashi ORCID,Suna Erdem ORCID,Sara McArdle ORCID,Hervé Tiriac ORCID,Partha Ray ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4303646959

National Institutes of Health

Grant: 1R01CA254268-01A1

Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer

National Institutes of Health

Grant: 3P30CA023100-25S4

Specialized Cancer Center Support Grant

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/10/06/2022.10.04.510847.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.10.04.510847

repositoryhttps://doi.org/10.1101/2022.10.04.510847

https://doi.org/10.1136/jitc-2022-006133

Fields of Study

Microbial Inactivation MethodsMicrofluidic and Bio-sensing Technologies0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

Irreversible electroporationMedicinePancreatic cancerImmune systemImmunofluorescenceMetastasisEx vivoPathologyAntibodyCancer researchCancerIn vivoElectroporationInternal medicineImmunologyBiologyMaleOncology and Carcinogenesis610AntibodiesMiceRare DiseasesTumor MicroenvironmentAnimalsAntigensRC254-282Gastrointestinal NeoplasmsAntigen PresentationBiomedical and Clinical SciencesLiver DiseaseLiver NeoplasmsImmunityNeoplasms. Tumors. Oncology. Including cancer and carcinogensPancreatic NeoplasmsOncolytic and Local ImmunotherapyGood Health and Well Being5.1 PharmaceuticalsNeoplasmImmunizationImmunotherapyDigestive DiseasesBiotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being